Respiratory Infections

A brief overview of our recent coverage.

Opaganib is set to be evaluated against SARS-CoV-2 in a multi-center, randomized, parallel arm, double-blind, placebo-controlled study.

The status of emergency departments in the city during the pandemic's migration west.

Deaths associated with pneumoconiosis fell 40% from 1999 to 2018, with the greatest decrease among coal workers cases, according to a new report.

Bradley Sherman, MD, shares insight as to what goes into a respiratory ventilator recovery unit.

A brief summary of the latest news.

A look at how the state became a belated hotspot, and what may help reduce future infection growth.

A brief on today's top ID news.

The Hong Kong researchers used online searches to quantify public interest in mask usage.

The finger-prick test showed 98.8% specificity for novel coronavirus in assessments including 1500 patients.

Where did things go wrong for the Grand Canyon State?

Video briefing on the day's top infectious disease news.

Given research into SARS-CoV-2 is taking place at unprecedented speed, the panel of IDSA experts had to decide on current best practices using science which is still in motion.

Patrick Soon-Shiong, MD, Chairman and CEO of ImmunityBio, explains why the firm's COVID-19 research benefits from drawing on a background in cancer.

A recent review of electronic health data revealed a 42% drop in emergency department visits during 4 weeks of the pandemic.

An overview of today's top infectious disease stories.

Patrick Soon-Shiong, MD, CEO of ImmunityBio, discusses the pandemic as a unique moment in world & American history.

In order to expand the potential uses of the drug against SARS-CoV-2, Gilead Sciences has announced plans to explore administration of remdesivir in an inhaled form.

A video summary of the latest infectious disease headlines.

Findings reveal that most unhealthy seniors and/or their families opt for comfort-directed care rather than life-sustaining treatment.

A video review of the latest ID news.

Pregnant women with COVID-19 typically experienced symptoms in their second and third trimester, a new study shows.

Vibeke Strand, MD, MACR, FACP, of the Division of Immunology/Rheumatology at Stanford University School of Medicine, discusses ongoing AI research in her field.

In a new analysis of Guangzhou city contact tracing data, investigators examined secondary attack rates of SARS-CoV-2.

An overview of 3 recent infectious disease news stories.